-
Product Insights
NewCognitive Impairment – Drugs In Development, 2024
Empower your strategies with our Cognitive Impairment – Drugs In Development, 2024 report and make more profitable business decisions. Cognitive impairment is a condition characterized by a decline in cognitive functions, such as memory, attention, and problem-solving skills. It can range from mild to severe and may result from various causes, including aging, neurodegenerative diseases (like Alzheimer's), vascular disorders, traumatic brain injuries, infections, medication side effects, mental health issues, nutritional deficiencies, or environmental factors. Symptoms can include memory loss, confusion, difficulty...
-
Product Insights
NewTraumatic Brain Injury – Drugs In Development, 2024
Empower your strategies with our Traumatic Brain Injury – Drugs In Development, 2024 report and make more profitable business decisions. Traumatic brain injury (TBI) happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping, and memory or concentration problems. Risk factors include age. Certain types of traumatic brain injury increase the risk of developing...
-
Product Insights
Tshipi Borwa Mine
The Tshipi Borwa Mine is a manganese mine in South Africa. It is currently in operation. Empower your strategies with our Tshipi Borwa Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-107 in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AB-107 in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AB-107 in Psoriasis Drug Details:AB-107 is under development for the treatment of psoriasis. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNS-101 in Friedreich Ataxia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNS-101 in Friedreich Ataxia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JNS-101 in Friedreich AtaxiaDrug Details:JNS-101 is under development for the treatment of Friedreich’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PHIN-214 in Portal Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PHIN-214 in Portal Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PHIN-214 in Portal HypertensionDrug Details:PHIN-214 is under development for the treatment of portal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JW-100 in Herpes Labialis (Oral Herpes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JW-100 in Herpes Labialis (Oral Herpes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JW-100 in Herpes Labialis (Oral Herpes) Drug Details:JW-100 (CaniDermRX) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4381562 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-4381562 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GSK-4381562 in Solid Tumor Drug Details:GSK4381562 is under development for the treatment of...
-
Product Insights
MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
MRI Systems Pipeline Market Report Overview Magnetic Resonance Imaging (MRI) generates clear and detailed images of internal organs and tissues using radiofrequency and a strong magnetic field. MRI is generally preferred for the diagnosis of brain and other neurological disorders. The 3T, 1.5T and 0.2-1.2T MRI systems have been tracked under this category. The MRI Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...